Small biotech Oak Hill will bring Roche's Angelman drug back to life

Roche devastated the Angelman syndrome community in 2023, when it ended clinical development of rugonersen, a treatment candidate for the rare neurodevelopmental condition. But after

Apr 15, 2025 - 12:01
 0
Small biotech Oak Hill will bring Roche's Angelman drug back to life
Roche devastated the Angelman syndrome community in 2023, when it ended clinical development of rugonersen, a treatment candidate for the rare neurodevelopmental condition. But after